Oasmia Pharmaceutical AB Profit Loss From Operating Activities
Oasmia Pharmaceutical AB reported Profit Loss From Operating Activities of -SEK 103.72 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Cash Flow › Operating Activities
ifrs-full:ProfitLossFromOperatingActivities · last filed 2018-09-14
| Period end | Profit Loss From Operating Activities 12 month |
|---|---|
| 2018-04-30 | -103.72M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | -140.48M SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | -132.69M SEK 20-F · filed 2018-09-14 |